Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entrada Therapeutics (TRDA) Treasury Shares: 2022-2024

Historic Treasury Shares for Entrada Therapeutics (TRDA) over the last 3 years, with Dec 2024 value amounting to $2.0 million.

  • Entrada Therapeutics' Treasury Shares rose 17.03% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year increase of 17.03%. This contributed to the annual value of $2.0 million for FY2024, which is 55.18% up from last year.
  • Latest data reveals that Entrada Therapeutics reported Treasury Shares of $2.0 million as of FY2024, which was up 55.18% from $1.3 million recorded in FY2023.
  • In the past 5 years, Entrada Therapeutics' Treasury Shares registered a high of $2.0 million during FY2024, and its lowest value of $463,964 during FY2022.
  • Its 3-year average for Treasury Shares is $1.2 million, with a median of $1.3 million in 2023.
  • Data for Entrada Therapeutics' Treasury Shares shows a peak YoY spiked of 173.40% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Entrada Therapeutics' Treasury Shares stood at $463,964 in 2022, then surged by 173.40% to $1.3 million in 2023, then surged by 55.18% to $2.0 million in 2024.